HOW ARE YOU TOMORROW
DEAD

Serial Number

77799340

Owner

Lab 21 Limited

Attorney

Mark B. Harrison

Filing Date

Aug 7, 2009

Add to watchlist:

No watchlists yet
View on USPTO

HOW ARE YOU TOMORROW Trademark

Serial Number: 77799340 • Registration: 4255661

HOW ARE YOU TOMORROW is a trademark filed by Lab 21 Limited on August 7, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

Lab 21 Limited (4 trademarks)

184 Cambridge Science Park, Cambridge
Cambridgeshire CB4OGA , GB

Entity Type: 03

Trademark Details

Filing Date

August 7, 2009

Registration Date

December 11, 2012

Published for Opposition

September 25, 2012

Cancellation Date

July 12, 2019

Goods & Services

Medical and veterinary preparations being chemical reagents; medical and veterinary diagnostic preparations; medical and veterinary testing preparations for investigation, testing, analysis, characterization or monitoring of biological material; reagents for medical and veterinary purposes; medical and veterinary preparations for the diagnosis of infectious diseases, blood grouping, virology, genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, serology, immunology, haematology, metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics and gynaecology; preparations for the testing for and in relation to infectious diseases, blood grouping, virology, genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, serology, immunology, haematology, metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics and gynaecology; medical kits comprised of assays for diagnosis and testing of biological material in the medical and veterinary fields

Printed matter, namely, leaflets, brochures, labels, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, articles, reports, press releases, promotional literature and product guides in the medical and veterinary fields; packaging for products, namely, packaging made from paper, cardboard, plastics, metallic foil, and combinations thereof; printed matter, namely, instructional leaflets and information sheets, and brochures and promotional literature for use with diagnostic, screening, analyzing, chemical, biochemical and biological detection, monitoring and control apparatus and instruments, medical and veterinary apparatus and instruments in the medical and veterinary field; printed matter, namely, instructional leaflets and information sheets, brochures, promotional literature

Medical and veterinary services relating to diagnostic testing; medical and veterinary services in the sampling, testing, screening, monitoring and diagnosis of medical and veterinary conditions

Diagnostic, screening and analysis apparatus and instruments for use in medical and veterinary diagnosis, screening, analysis and monitoring of biological material; chemical, biochemical and biological detection apparatus and instruments for obtaining, sampling, analyzing and monitoring of biological material for medical and veterinary purposes; diagnostic and testing apparatus and instruments for use in diagnosing, testing, analyzing and monitoring of biological material for medical and veterinary purposes; automated sampling, testing and diagnostic apparatus and instruments for use in automated obtaining, sampling, analysis and monitoring of biological material for medical and veterinary purposes; kits for medical and veterinary testing purposes consisting of reagents, apparatus and instruments for testing biological material; mobile apparatus and instruments for testing biological material in the medical and veterinary field; medical and veterinary apparatus and instruments for diagnostic and testing purposes in relation to infectious diseases, blood grouping, virology, genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, serology, immunology, haematology, metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics and gynaecology

Scientific research services; industrial research services in the field of diagnosis, screening, analysis and monitoring of solids, liquids, gases or biological material; biological, biochemical and chemistry research services; drug discovery services; clinical trial services; preclinical services, namely, investigation in the nature of characterization, optimization, profiling, efficacy, toxicity and therapeutic effect of drugs and diagnosis, analysis, testing and monitoring of biological and chemical material for the purpose of identification and characterization of medical and veterinary conditions, illnesses and diseases; clinical diagnostic services, namely, investigation in the nature of diagnosis, analysis, testing and monitoring of patients for the purpose of identification and characterization of patients before, during and after therapy or treatment; diagnostic, analytical, testing and monitoring services relating to pharmaceutical lead identification and optimization, drug resistance profiling and selection, and cellular and pharmaceutical toxicity; scientific research and medical consultancy services in the fields of preclinical and clinical trials; medical and veterinary research services; consulting services in the field of environmental research

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 12, 2019 C8..
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 31, 2013 COC.
SEC 7 REQUEST FILED
Jan 17, 2013 AMD7
PAPER RECEIVED
Jan 17, 2013 MAIL
REGISTERED-PRINCIPAL REGISTER
Dec 11, 2012 R.PR
PUBLISHED FOR OPPOSITION
Sep 25, 2012 PUBO
NOTICE OF PUBLICATION
Sep 5, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 20, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2012 TROA
NON-FINAL ACTION MAILED
Apr 20, 2012 CNRT
NON-FINAL ACTION WRITTEN
Apr 20, 2012 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 17, 2012 ZZZX
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Apr 5, 2012 PBER
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 27, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 6, 2012 TROA
NON-FINAL ACTION MAILED
Sep 7, 2011 CNRT
NON-FINAL ACTION WRITTEN
Sep 7, 2011 CNRT
AMENDMENT FROM APPLICANT ENTERED
Aug 15, 2011 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2011 CRFA
ASSIGNED TO LIE
Aug 15, 2011 ALIE
PAPER RECEIVED
Aug 3, 2011 MAIL
INQUIRY AS TO SUSPENSION MAILED
Feb 10, 2011 CNSI
SUSPENSION INQUIRY WRITTEN
Feb 9, 2011 CNSI
LETTER OF SUSPENSION MAILED
Aug 9, 2010 CNSL
SUSPENSION LETTER WRITTEN
Aug 9, 2010 CNSL
FINAL REFUSAL MAILED
Jun 8, 2010 CNFR
FINAL REFUSAL WRITTEN
Jun 8, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 17, 2010 TROA
NON-FINAL ACTION MAILED
Nov 17, 2009 CNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2009 CNRT
ASSIGNED TO EXAMINER
Nov 12, 2009 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 17, 2009 CHAN
ASSIGNED TO LIE
Sep 14, 2009 ALIE
PAPER RECEIVED
Sep 10, 2009 MAIL
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2009 NWOS
NEW APPLICATION ENTERED
Aug 11, 2009 NWAP